Hyperthermic intraperitoneal chemotherapy: Nomenclature and modalities of perfusion

Journal of Surgical Oncology

Volumn 98, Issue 4, 2008, Pages 242-246

  Glehen, Olivier ^a,b   Cotte, Eddy ^a,b   Kusamura, Shigeki ^c   Deraco, Marcello ^c   Baratti, Dario ^c   Passot, Guillaume ^a,b   Beaujard, Annie Claude ^a,b   Noel, Gilly Francois ^a,b  

^a CENTRE HOSPITALIER LYON SUD   (France)

^b UNIVERSITÉ CLAUDE BERNARD LYON 1   (France)

^c NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

Hyperthermia; Intraperitoneal chemotherapy; Peritoneal carcinomatosis; Techniques

Indexed keywords

CISPLATIN; DOXORUBICIN; FLUOROURACIL; MITOMYCIN; MITOMYCIN C; OXALIPLATIN;

ANTINEOPLASTIC ACTIVITY; CANCER CHEMOTHERAPY; CANCER RECURRENCE; CARCINOMATOUS PERITONITIS; CLOSED ABDOMINAL TECHNIQUE; CONFERENCE PAPER; CYTOTOXICITY; DRUG PENETRATION; HUMAN; HYPERTHERMIA; HYPERTHERMIC INTRAPERITONEAL CHEMOTHERAPY; MORBIDITY; MORTALITY; NOMENCLATURE; OPEN ABDOMINAL TECHNIQUE; OVERALL SURVIVAL; PERFUSION; PERITONEAL CAVITY EXPANDER; PRIORITY JOURNAL; SAFETY; SCIENTIFIC LITERATURE; SEMI OPENED ABDOMINAL TECHNIQUE; TEMPERATURE MEASUREMENT; TREATMENT OUTCOME;

ANTINEOPLASTIC AGENTS; CHEMOTHERAPY, ADJUVANT; CHEMOTHERAPY, CANCER, REGIONAL PERFUSION; HUMANS; HYPERTHERMIA, INDUCED; INFUSIONS, PARENTERAL; PERITONEAL NEOPLASMS; TERMINOLOGY AS TOPIC;

EID: 50849090665     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.21061     Document Type: Conference Paper

References (33)

1. Verwaal VJ, van Ruth S, de Bree E, et al.: Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer. J Clin Oncol 2003;21:3737-3743.
2. Gonzalez-Moreno S: Peritoneal surface oncology: A progress report. Eur J Surg Oncol 2006;32:593-596.
3. Esquivel J, Vidal-Jove J, Steves MA, et al.: Morbidity and mortality of cytoreductive surgery and intraperitoneal chemotherapy. Surgery 1993;113:631-636.
4. Jacquet P, Averbach A, Stephens AD, et al.: Heated intraoperative intraperitoneal mitomycin C and early postoperative intraperitoneal 5-fluorouracil: Pharmacokinetic studies. Oncology 1998;55:130-138.
5. Glehen OKF, Sugarbaker PH, Elias D, et al.: Cytoreductive surgery combined whith perioperative intraperitoneal chemotherapy for the management of peritoneal carcinomatosis from colorectal cancer: A multi-institutional study. J Clin Oncol 2004;22:3284-3292.
6. Esquivel J, Angulo F, Bland RK, et al.: Hemodynamic and cardiac function parameters during heated intraoperative intraperitoneal chemotherapy using the open "coliseum technique". Ann Surg Oncol 2000;7:296-300.
7. Crile G Jr: The effects of heat and radiation on cancers implanted on the feet of mice. Cancer Res 1963;23:372-380.
8. Elias DM, Ouellet JF: Intraperitoneal chemohyperthermia: Rationale, technique, indications, and results. Surg Oncol Clin N Am 2000;10:915-933, xi.
9. Glehen OMF, Gilly FN: Peritoneal carcinomatosis from digestive tract cancer: New management by cytoreductive surgery and intraperitoneal chemohyperthermia. Lancet Oncol 2004;5:219-228.
10. Sugarbaker PH: Intraperitoneal chemotherapy and cytoreductive surgery for the prevention and treatment of peritoneal carcinomatosis and sarcomatosis. Semin Surg Oncol 1998;14:254-261.
11. Elias D, Benizri E, Di Pietrantonio D, et al.: Comparison of two kinds of intraperitoneal chemotherapy following complete cytoreductive surgery of colorectal peritoneal carcinomatosis. Ann Surg Oncol 2007;14:509-514.
12. Sarnaik AA, Sussman JJ, Ahmad SA, et al.: Technology of intraperitoneal chemotherapy administration: A survey of techniques with a review of morbidity and mortality. Surg Oncol Clin N Am 2003;12:849-863.
13. Szafnicki K, Narce C: Towards a "crippled-mode" operation of an industrial wastewater treatment plant. Water Res 2006;40:579-587.
14. Elias D, Antoun S, Goharin A, et al.: Research on the best chemohyperthermia technique of treatment of peritoneal carcinomatosis after complete resection. Int J Surg Investig 2000;1:431-439.
15. Stephens AD, Alderman R, Chang D, et al.: Morbidity and mortality analysis of 200 treatments with cytoreductive surgery and hyperthermic intraoperative intraperitoneal chemotherapy using the coliseum technique. Ann Surg Oncol 1999;6:790-796.
16. Stuart OA, Stephens AD, Welch L, et al.: Safety monitoring of the coliseum technique for heated intraoperative intraperitoneal chemotherapy with mitomycin C. Ann Surg Oncol 2002;9:186-191.
17. Gonzalez-Bayon L, Gonzalez-Moreno S, Ortega-Perez G: Safety considerations for operating room personnel during hyperthermic intraoperative intraperitoneal chemotherapy perfusion. Eur J Surg Oncol 2006;32:619-624.
18. Elias D, Blot F, El Otmany A, et al.: Curative treatment of peritoneal carcinomatosis arising from colorectal cancer by complete resection and intraperitoneal chemotherapy. Cancer 2001;92:71-76.
19. Glehen O, Osinsky D, Cotte E, et al.: Intraperitoneal chemohyperthermia using a closed abdominal procedure and cytoreductive surgery for the treatment of peritoneal carcinomatosis: Morbidity and mortality analysis of 216 consecutive procedures. Ann Surg Oncol 2003;10:863-869.
20. Kusamura S, Younan R, Baratti D, et al.: Cytoreductive surgery followed by intraperitoneal hyperthermic perfusion: Analysis of morbidity and mortality in 209 peritoneal surface malignancies treated with closed abdomen technique. Cancer 2006;106:1144-1153.
21. Shen P, Levine EA, Hall J, et al.: Factors predicting survival after intraperitoneal hyperthermic chemotherapy with mitomycin C after cytoreductive surgery for patients with peritoneal carcinomatosis. Arch Surg 2003;138:26-33.
22. Sugarbaker PH, Alderman R, Edwards G, et al.: Prospective morbidity and mortality assessment of cytoreductive surgery plus perioperative intraperitoneal chemotherapy to treat peritoneal dissemination of appendiceal mucinous malignancy. Ann Surg Oncol 2006;13:635-644.
23. Verwaal VJ, van Tinteren H, Ruth SV, et al.: Toxicity of cytoreductive surgery and hyperthermic intra-peritoneal chemotherapy. J Surg Oncol 2004;85:61-67.
24. Porcheron J, Talabard JN, Breton C, et al.: Intraperitoneal chemohyperthermia for peritoneal carcinomatosis: Original modeling, clinical tolerance and results study about 30 patients. Hepatogastroenterology 2000;47:1411-1418.
25. Szafnicki K, Cournil M, O'Meara D, et al.: Modelling of intraperitoneal chemohyperthermia: Experimental study and identification of certain thermal aspects. Bull Cancer 1998;85:160-166.
26. Jacquet P, Stuart OA, Chang D, et al.: Effects of intra-abdominal pressure on pharmacokinetics and tissue distribution of doxorubicin after intraperitoneal administration. Anticancer Drugs 1996;7:596-603.
27. Esquis P, Consolo D, Magnin G, et al.: High intra-abdominal pressure enhances the penetration and antitumor effect of intraperitoneal cisplatin on experimental peritoneal carcinomatosis. Ann Surg 2006;244:106-112.
28. Fujimura T, Yonemura Y, Fushida S, et al.: Continuous hyperthermic peritoneal perfusion for the treatment of peritoneal dissemination in gastric cancers and subsequent second-look operation. Cancer 1990;65:65-71.
29. Fujimura T, Yonemura Y, Fujita H, et al.: Chemohyperthermic peritoneal perfusion for peritoneal dissemination in various intra-abdominal malignancies. Int Surg 1999;84:60-66.
30. Hirose K, Katayama K, Iida A, et al.: Efficacy of continuous hyperthermic peritoneal perfusion for the prophylaxis and treatment of peritoneal metastasis of advanced gastric cancer: Evaluation by multivariate regression analysis. Oncology 1999;57:106-114.
31. Yonemura Y, Bandou E, Kinoshita K, et al.: Effective therapy for peritoneal dissemination in gastric cancer. Surg Oncol Clin N Am 2003;12:635-648.
32. Rat P, Benoit L, Cheynel N, et al.: Intraperitoneal chemohyperthermia with "overflow" open abdomen. Ann Chir 2001;126:669-671.
33. Sugarbaker PH: An instrument to provide containment of intraoperative intraperitoneal chemotherapy with optimized distribution. J Surg Oncol 2005;92:142-146.